Trimebutine "No compensation plan" Taiji group or face lawsuit

Once overwhelming star graceful stature as a sign of trimebutine and other weight loss medicine ads will soon disappear without trace.　　October 30, the state Food and Drug Administration on its website issued a notice to require domestic production enterprises to "stop the production, sale and use of sibutramine", the reason is "too big negative risk." The announcement of the introduction of the weight loss products industry is "extinction." As Trimebutine is the star product of the listed company Taiji Group (600129,SH), Trimebutine's retreat may affect the company. Recently, Tai Chi Group News Center Zhang in the media interview, said clearly, "although the company will no longer produce Qu Mei slimming capsules, but retain the melody of the United States brand, and the melody of the United States products in line with national standards, so the long time to take the beauty of consumers have no compensation plan."　　"Some analysts believe that in the long run, the product's lower market, the impact on the company's performance will not be too big."　　By this effect, Tai Chi Group yesterday (November 1) fell 2.64% in reverse, ranked fifth in the decline, very weak performance. To Tai Chi this year, 40 million as a result of the production of over-the-counter drug-oriented listed companies, Taiji group's product line mainly covers respiration, digestion, cardio-cerebrovascular, genitourinary and other fields.　　The withdrawal of Trimebutine (sibutramine hydrochloride capsules) is the company's main products. It is understood that Sibutramine was listed in 1997 abroad, 2000 was approved in China listed, belongs to weight loss adjuvant treatment drugs.　　Trimebutine in August 2000 in the domestic official listing, has been 10 years.　　In October 2010, the state-related authorities gave the guidance that sibutramine currently has fewer patients in the market according to the indications, that the weight loss after discontinuation is less consistent, and may increase the risk of serious cardiovascular risk and weight loss treatment greater than the benefits. "We have no beauty pills, last week we have all the shelves, and then we will not sell." Yesterday (November 1), The daily economic news reporter in the identity of the consumer inquiries Wuhan more than 10 street pharmacies, have received a similar answer.　　Reporters see, previously placed in the pharmacy prominent position of the star product beauty slimming capsules have disappeared. In an interview with the Daily Economic news, Lio Van, an analyst with China Securities, said Taiji group's trimebutine and another product Taro (rosiglitazone sodium tablets) 2009 sales total of about 250 million yuan, is expected to 2010 total sales of more than 300 million yuan, accounting for the company's main business sales of about 17%, contribution margin 30%　　About。　　According to the Tai Chi Group Bulletin, the initial calculation, the cessation of sales of sibutramine capsules, will affect the sales revenue of nearly 40 million yuan this year, accounting for about 0.8% of the company's sales revenue, and the impact of the profit will need to be further verified. Lio Van told the Daily Economic news reporter, "The impact of revenue 40 million yuan refers to the company's four quarters of the product's revenue, the short-term impact on the company is certainly there, but, in recent years, Taiji group, the beauty of the sales of products, in fact, has been in a stagnant state, the income of these yearsYuan, so in the long run, the product of the next city, the impact on the company's performance will not be too big. Zhou Jing of the National Union Securities also said, "Qu Mei accounted for Taiji group revenue is not high, the impact on its performance is limited."　　"No way." Tai chi or the face of litigation is simply to stop the production, sale and recall of this product, the Tai Chi Group as the representative of the weight loss drug production enterprises "old debt" may be far from closed. In addition to the National ADR Monitoring Center has now been statistically 298 cases of sibutramine related adverse reactions of consumers (data dated from January 1, 2004 to January 15, 2010), in the vast number of consumers have set off a wave of claims to Taiji group, and even consumers posted on the network said "　　Eat the beauty of the side effect is very big, hope to unite other consumer collective public Prosecution Taiji group. 9 o'clock last evening Xu, "Daily economic news" reporter contacted the Tai Chi Group spokesperson Zhang. On the recall of Trimebutine products, she said: "We will recall the products that need to be recalled in accordance with the requirements of the relevant national authorities." "However, for consumers who have used the problem product, she said," the company has no compensation plan, but will be based on the actual situation of each consumer to return, specifically to see the use of products. "The consumer is entitled to bring a lawsuit, the enterprise is necessary to compensate for it," said Zeng Zhihong, chairman of the Han Lu law firm, "for consumers who wish to safeguard their rights through legal means, they first need to examine and identify the relevant medical institutions and then bring a lawsuit."　　"Zeng Zhihong pointed out that the previous relevant provisions did not specify the use of sibutramine weight loss products is illegal, until the recent introduction of the law to create new irregularities, however, Taiji group cited the" law not retroactive "principle of the application of the scope of a certain limit. Although the principle of "law does not go back to the past" refers to the inability to use the current provisions to restrain the previous acts, but this particular case is concerned with civil rights, but also the right to health of citizens, so certainly belong to the ' law to the back of the past ' special cases. However, the current situation in the jurisprudence still has some controversy, need to see the court's final judgment. Zeng Zhihong stressed that the right to health of citizens, the current law scholars generally believe that, since the development of science and technology to find that the composition of the human body is adverse, the introduction of new laws and regulations, then the new regulations should be investigated.　　This is a distinction between public and private rights, and this incident is a violation of private rights. "As a relatively high-yield industry such as the pharmaceutical industry, higher economic returns mean higher risks," he said. Companies in the industry have to take risks and not just want to bring in all the proceeds and risk.　　"Zeng Zhihong said. For the trimebutine products of the successive spokesmen Gong Li, Guanqi and the current spokesperson Fan Bingbing may also be difficult to escape joint responsibility. According to the relevant provisions of the advertising law, "advertising other participants who participate in advertising endorsement, certification and Recommendation" also act as the main body of the advertising campaign, which is included in the scope of regulation, and the subject of joint and several liabilityExtended to individuals. "Other participants in advertising", in addition to the corresponding administrative responsibility, civil liability, constitute a crime, but also should be held criminally responsible. In the interview, Ms. Zhang also revealed that Taiji group is developing some new products about women's beauty, "we will announce it immediately, but not on weight loss." ”